Private Advisor Group’s Medifast MED Stock Holding History

Private Advisor Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,965	Closed	-$273K	–	2343
2023 Q2	$273K	Sell	2,965 -252	-8%	-$22.4K	﹤0.01%	1687
2023 Q1	$333K	Buy	+3,217	New	+$357K	﹤0.01%	1524
2022 Q3	–	Sell	-5,866	Closed	-$1.06M	–	2047
2022 Q2	$1.06M	Sell	5,866 -8,332	-59%	-$1.49M	0.01%	1037
2022 Q1	$2.42M	Buy	14,198 +25	+0.2%	+$4.71K	0.02%	723
2021 Q4	$2.97M	Sell	14,173 -13,709	-49%	-$2.83M	0.02%	656
2021 Q3	$5.37M	Buy	27,882 +13,750	+97%	+$3.38M	0.03%	481
2021 Q2	$4M	Hold	14,132	–	–	0.03%	482
2021 Q1	$2.99M	Sell	14,132 -28	-0.2%	-$6.7K	0.03%	553
2020 Q4	$2.78M	Buy	+14,160	New	+$2.5M	0.03%	542
2020 Q3	–	Sell	-791	Closed	-$110K	–	2678
2020 Q2	$110K	Buy	+791	New	+$72.6K	﹤0.01%	1653

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Advisor Group's MED Position: Q3 2023 in Review

Private Advisor Group sold out of Medifast (MED) in Q3 2023, closing a stake of 2,965 shares — an estimated $273K sold.

Private Advisor Group first reported a position in MED in Q2 2020 and held it in 10 quarters. The position peaked at $5.37M in Q3 2021. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Private Advisor Group reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Private Advisor Group sold 2,965 Medifast shares in Q3 2023, an estimated $273K.
Private Advisor Group first reported a position in Medifast in Q2 2020 and held it in 10 quarters.
Private Advisor Group's Medifast position peaked at $5.37M in Q3 2021.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Private Advisor Group's 13F filing for Q3 2023, filed 3 Nov 2023.